instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
The Baltimore Sun reported that Catherine Pugh continues to convalesce at home and is under doctors' supervision. She abruptly took leave April 1. "While her well-known tireless energy has been diminished by this illness, her doctors are confident she will recover her health and strength in due course," Pugh's personal attorney, Steven Silverman, told The Sun. "I know she is grateful for the good wishes of concern and support that she's received." Pugh was admitted to Johns Hopkins Hospital in late March, before she took leave and just as the scandal began to grow. The scandal involves her sales of her "Healthy Holly" children's books to the University of Maryland Medical System, where she sat on the board. Details also emerged that she had collected hundreds of thousands of dollars for her books from entities doing business with the city of Baltimore. Maryland Gov. Larry Hogan asked a state prosecutor to begin a criminal investigation. Many city and state lawmakers have called for her resignation. All but one member of the Baltimore City Council have called for Pugh to step down. U.S. Rep. Andy Harris told The Sun that Baltimore needs a new leader. "There are enough questions legitimate questions cast about this that I think the mayor probably can no longer be an effective leader of the city," the Republican said. But the people closest to Pugh say her health, not the scandal, is keeping her from public view. "She's recovering day by day," said James Bentley, her spokesman. "She's focused on getting healthy, and remains committed to Baltimore." The Sun reported that Pugh, 69, has not publicly faced serious medical issues previously. Neither she nor her advisers have offered details about the nature of her pneumonia. Dr. Paul Auwaerter, clinical director of the division of infectious diseases at the Johns Hopkins University School of Medicine, told the newspaper that recovery times can vary. After people seek treatment, and particularly if they've been hospitalized, they are on average "feeling better within 48 to 72 hours," though it "might take five to seven days" to bounce back completely, he said. But he said it can take longer if complicating factors are involved, such as stress. ___ Information from: The Baltimore Sun, http://www.baltimoresun.com
answer:
Advisers: Baltimore's mayor still recovering from pneumonia.

question:
"The article doesn't mention costs of angioplasty or costs of medications, which presumably must be taken for the rest of one's life. The article does mention that angioplasty is expensive, but does not provide real numbers or comparisons. The story provides absolute numbers of the primary endpoint over a 4-year period ""17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure results considered to be statistically the same."" The story states that there was a worrisome trend toward more heart attacks in people who received late angioplasty compared to those who received just medications,although the story also tells readers that this could have been a statistical fluke or due to chance. However, other harms of the procedure were not discussed, including risks of the procedure itself, including bleeding, infection, or emotional distress/anxiety. The article also does not discuss risks of the alternative, e.g. medications, which have side effects, costs, or inconvenience. But, the story does discuss the main harm found in the study, e.g. a trend toward increased heart attacks. The research is important because it is a randomized controlled trial and the first such trial to be conducted for the clinical situation of late angioplasty in people with few to no symptoms after their heart attack. The story tells readers that enrollment of patients was delayed because ""doctors were unwilling to risk randomly assigning patients to drug treatment alone,"" indirectly stating that the study was a randomized trial. While an astute reader could probably pick up that this was a randomized trial, this fact could have been clearer. In addition, there islittlecontext around this being the first randomized trial for this clinical situation (as opposed to retrospective observational studies), although the story does tell readers that the results were surprising and that they could change guidelines. The story appropriately describes a heart attack, and more importantly, reinforces that early opening of the artery to restore blood flow to the heart after heart attack is still beneficial and that these results don't apply to that population or indeed the majority of people receiving angioplasties. No obvious disease mongering. The article provides an independent source of information from the chairman of theAmerican Heart Association program committee that reviewed the research. The story also provides information from the director of the National, Heart, Lung, and Blood Institute, but tells readers that this organization largely funded the research, therefore disclosing potential conflicts of interest. The story tells readers that the alternative that was tested in the latest research was medications, including those to lower blood pressure and cholesterol, aspirin, and anti-clotting drugs. The story could have mentioned beta-blockers specifically, since the protective effect of drug treatment may come from this family of drugs, although this is not yet proven. And the story could have been clearer about the course of treatment, e.g. that these medications are generally taken for the rest of one's life. The story tells readers that the usual treatment for people suffering a heart attackis angioplasty, even for a subset of people who weren't treated right away (the study population)/ The article also tells readers that the tendency to perform angioplasty electively (3 to 28 days after the event) was so strong, that recruitment to the study was prolonged in order to find enough patients (and their doctors) willing to participate in the study. It's widely understood that angioplasty and standard drug therapy after heart attackare not new. The article provides independent sources of information not included in the press release."
answer:
Study says late angioplasty futile

question:
"TXA costs $10 per treatment, according to the story. Although this cost is characterized as low, the story could have noted that the price may be prohibitively expensivein many poor countries. The story focuses on mortality difference between the TXA and placebo groups and presents the results in absolute terms. It helpfully notes that TXA would need to be adminstered to 66 patients to prevent one death. Although it passes along the claim that TXA might save ""tens of thousands of people"" without questioning it,the storydoesn't hype the assertion quite as vigorouslyas the competing coverage. The story mentioned there was no increase in deaths due to blood clots in the TXA group. We understand it's a blog brief so this is sufficient. The story provides the bare essentials noting the outcomes in absolute numbers and in number needed to treat. Unfortunately, several important facts were notreportedincluding the number of sites involved, the number of countries and other essential attributes of the study. Nonetheless, we'll give it the benefit of the doubt. No disease-mongering in this story. It's difficult to find room for an independent perspective in a 245-word brief, and this story didn't find the room. Numerousother pro-coagulatoryagents are usedto help control bleeding in trauma patients. The story didn't mention any of them. The story states that TXA is a 25-year-old medicine that is approved in the U.S. to prevent bleeding in hemophiliacs who have teeth pulled. The story mentions that TXA is already used to control bleeding during surgery and doesn't portray the treatment as new. While there's no evidence that this story lifted anything directly from a news release, we can't be sure to what extent this story may have relied on one. We'll call it not applicable."
answer:
Generic Drug Could Save Many Trauma Patients